Explainer: New Drug Slows Alzheimer’s But Comes with Caveats

January 9, 2023

(Associated Press) – A new Alzheimer’s drug is hitting the market — the first with clear-cut evidence that it can slow, by several months, the mind-robbing disease. It’s a long-needed new treatment, but experts also are voicing a lot of caution: The drug isn’t a cure, it’s only intended for early-stage patients, requires IV doses every two weeks, and comes with some safety concerns. It’s not even clear just how noticeable that modest benefit will be in people’s everyday lives. (Read More)